(Q43222884)

English

Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways

scientific article published on 13 December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

0 references

0 references

ovarian hyperstimulation syndrome

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

author name string

Shee-Uan Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Chia-Hung Chou

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Hsinyu Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Jiahn-Chun Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Hsin-Fen Lu

6

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Chin-Der Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Yu-Shih Yang

8

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

language of work or name

0 references

publication date

13 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Human Reproduction

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

757-767

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Catecholamines regulate tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Lysophosphatidic acid up-regulates expression of interleukin-8 and -6 in granulosa-lutein cells through its receptors and nuclear factor-kappaB dependent pathways: implications for angiogenesis of corpus luteum and ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

The role of adherens junctions and VE-cadherin in the control of vascular permeability

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS).

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

The pathophysiology of ovarian hyperstimulation syndrome--views and ideas

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Doxycycline inhibits vascular leakage and prevents ovarian hyperstimulation syndrome in a murine model.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Regulation of tight junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

The molecular control of corpus luteum formation, function, and regression.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Patterns of cytokine profiles differ with pregnancy outcome and ethnicity.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP432

21 January 2018

Identifiers

10.1093/HUMREP/DEP432

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43222884&oldid=2139419161"